A new yeast strain called Saccharomyces cerevisiae ABO1, discovered in toddy palm nectar, reduced cholesterol by 86.90% in laboratory tests, matching the performance of an established probiotic strain already used medically. According to Gram Research analysis, this finding suggests toddy palm nectar contains promising natural probiotics, though human studies are needed before this yeast could be used as a treatment.
Researchers discovered a new type of yeast called Saccharomyces cerevisiae ABO1 that can lower cholesterol levels in the body. Scientists found this yeast in toddy palm nectar and tested it against 62 other yeast strains. The ABO1 strain reduced cholesterol by nearly 87%, matching the performance of a well-known probiotic yeast already used in medicine. This discovery could lead to new probiotic supplements that help people manage their cholesterol naturally. The findings suggest that traditional foods like toddy palm nectar may contain helpful microorganisms we haven’t fully explored yet.
Key Statistics
A 2026 laboratory study found that Saccharomyces cerevisiae ABO1, isolated from toddy palm nectar, reduced cholesterol by 86.90%, nearly identical to the reference probiotic strain Saccharomyces boulardii at 86.74%.
Among 63 yeast isolates screened from toddy palm nectar, five strains showed probiotic characteristics, with ABO1 significantly outperforming the others, ABO11 achieved 65.23% cholesterol reduction, while ABO20 and ABO21 managed only 14.09% and 12.79% respectively.
Chemical analysis of the ABO1 yeast culture revealed the presence of organic acids and bioactive metabolites with therapeutic potential, suggesting multiple mechanisms through which the strain may benefit health.
The Quick Take
- What they studied: Can yeast strains found in toddy palm nectar lower cholesterol levels in the body?
- Who participated: Scientists screened 63 different yeast isolates collected from toddy palm nectar. Five strains showed probiotic properties, meaning they could potentially benefit health. The study focused on laboratory testing rather than human participants.
- Key finding: The ABO1 yeast strain reduced cholesterol by 86.90% in laboratory tests, nearly identical to a reference probiotic strain (86.74%) already used medically. This was significantly better than the other four strains tested.
- What it means for you: This research suggests a new natural source for probiotic supplements that could help manage cholesterol. However, these are early laboratory findings, human studies would be needed before this yeast could be used as a treatment. Talk to your doctor before trying any new supplements.
The Research Details
Scientists collected yeast samples from toddy palm nectar and grew them in the laboratory. They tested 63 different yeast isolates to see which ones had probiotic properties, meaning they could survive stomach acid and potentially help the body. Five strains passed these initial tests. The researchers then focused on the best performer, ABO1, and used advanced laboratory techniques to identify exactly what type of yeast it was. They measured how well ABO1 could reduce cholesterol using two different scientific methods: spectrophotometry (measuring light absorption) and HPLC (a technique that separates and identifies chemical compounds). They also analyzed what beneficial compounds the yeast produced.
This research approach is important because it combines traditional food sources with modern scientific testing. Rather than creating something entirely new in a lab, scientists looked for helpful microorganisms that already exist in nature. This method has discovered many useful probiotics in the past. By testing multiple strains and comparing them to a known reference probiotic, the researchers could confidently say that ABO1 performs as well as established treatments.
The study used established laboratory methods and compared results to a reference strain, which strengthens the findings. However, this is laboratory research only, the yeast was tested in test tubes and petri dishes, not in human bodies. The study doesn’t specify the exact sample size for some analyses. Published in a peer-reviewed journal, which means other scientists reviewed the work before publication. The main limitation is that these results don’t yet prove the yeast would work the same way in people.
What the Results Show
Among the 63 yeast isolates tested, five strains showed probiotic characteristics. The ABO1 strain emerged as the clear winner, reducing cholesterol by 86.90% in laboratory tests. This performance matched the reference strain Saccharomyces boulardii, which is already used as a probiotic supplement in medicine. The other four strains showed much lower cholesterol reduction: ABO11 reduced it by 65.23%, ABO13 by 58.46%, ABO20 by 14.09%, and ABO21 by 12.79%. The dramatic difference between ABO1 and the other strains suggests that this particular yeast has unique properties worth further investigation.
Chemical analysis of the ABO1 yeast culture revealed the presence of organic acids and bioactive metabolites, compounds that have known health benefits. These substances may contribute to the cholesterol-reducing effect, though more research is needed to understand exactly how. The presence of these beneficial compounds in the culture medium suggests that ABO1 doesn’t just work through one mechanism but may help health in multiple ways.
This research adds to growing evidence that traditional fermented foods and natural sources contain useful probiotics. Saccharomyces boulardii, the reference strain used in this study, is already approved for medical use in many countries. By showing that ABO1 performs equally well, this research suggests that toddy palm nectar could be another natural source of effective probiotic yeasts. Previous research has shown that different probiotic strains vary widely in their effectiveness, so finding a new high-performing strain is noteworthy.
This study was conducted entirely in laboratory conditions using test tubes and petri dishes. The results don’t prove that ABO1 would work the same way inside the human body, where conditions are much more complex. The study doesn’t include human trials, so we don’t know if people would experience the same cholesterol-reducing benefits. The exact mechanisms by which ABO1 reduces cholesterol aren’t fully explained. Additionally, the study doesn’t address safety concerns or potential side effects that might emerge in human use. More research, including animal studies and eventually human clinical trials, would be necessary before this yeast could be recommended as a treatment.
The Bottom Line
This research is promising but preliminary. According to Gram Research analysis, the ABO1 yeast shows strong laboratory potential for cholesterol reduction. However, no human studies have been conducted yet. Current recommendation: Monitor this research as it progresses toward human trials. Do not attempt to use this yeast as a treatment without medical supervision. If you’re interested in probiotic supplements for cholesterol management, continue using established options like Saccharomyces boulardii while this new strain undergoes further testing. Confidence level: Low for human application; High for laboratory validity.
This research is most relevant to: people with high cholesterol looking for natural options, researchers studying probiotics and cardiovascular health, supplement manufacturers exploring new ingredients, and people interested in traditional fermented foods. This research is NOT yet appropriate for: people seeking immediate treatment for high cholesterol, those who need proven medical interventions right now. Always consult your doctor about cholesterol management.
Laboratory research typically takes 3-5 years before moving to animal studies, and another 5-10 years before human clinical trials. If ABO1 follows this typical path, it could be 10-15 years before it might become available as a commercial probiotic supplement. In the meantime, established probiotic strains remain your best option.
Frequently Asked Questions
Can this new yeast strain help lower my cholesterol?
The ABO1 yeast reduced cholesterol by 86.90% in laboratory tests, matching established probiotics. However, these are early findings from test-tube studies only. Human trials haven’t been conducted yet, so it’s too early to recommend it as a treatment. Consult your doctor about proven cholesterol-management options.
When will this yeast be available as a supplement?
This research is in early stages. Typically, laboratory discoveries require 10-15 years of additional testing (animal studies, then human trials) before becoming commercial products. ABO1 is not yet available for consumer use and won’t be for several years at minimum.
How does this yeast compare to probiotics I can buy now?
In laboratory tests, ABO1 performed identically to Saccharomyces boulardii, a probiotic already available in stores. However, ABO1 hasn’t been tested in human bodies yet. Current probiotics have safety data from years of use; ABO1 does not. Stick with established options until more research is complete.
What is toddy palm nectar and can I eat it for cholesterol?
Toddy palm nectar is a sweet liquid from palm trees, traditionally consumed in some cultures. While it contains the beneficial ABO1 yeast, the nectar itself hasn’t been tested for cholesterol benefits in humans. Don’t rely on it as a treatment without medical guidance.
Are there any safety concerns with this yeast strain?
Safety hasn’t been evaluated in humans yet. While Saccharomyces cerevisiae is generally recognized as safe in food, this specific ABO1 strain requires safety testing before human use. Never self-treat with untested microorganisms without medical supervision.
Want to Apply This Research?
- Track your current cholesterol levels (total, LDL, HDL) and monitor them every 3 months. Record any probiotic supplements you take, including the specific strain and dosage. Note any digestive changes or side effects. This baseline data will be valuable if you eventually want to try new probiotic strains as they become available.
- While waiting for ABO1 to advance through research stages, use your app to track consumption of fermented foods that contain established probiotics: yogurt, kefir, sauerkraut, kimchi, and miso. Log your cholesterol-related habits like exercise, diet, and any supplements. This creates a foundation for understanding what works for your body.
- Set up quarterly cholesterol check-ins with your doctor and log the results in your app. Create a ‘Probiotic Research’ section to track emerging studies about new strains. When ABO1 eventually enters human trials, you’ll have historical data to compare against. This long-term approach helps you make informed decisions when new options become available.
This research describes laboratory findings only and has not been tested in humans. The ABO1 yeast strain is not approved for human consumption or medical use. Do not attempt to self-treat high cholesterol or any medical condition with untested microorganisms. Always consult with your healthcare provider before making changes to your cholesterol management plan or starting any new supplements. This article is for educational purposes and should not be considered medical advice. If you have high cholesterol, work with your doctor to develop a treatment plan based on proven, approved interventions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
